Skip to main content

Advertisement

SpringerLink
Log in

Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Survivin is a member of novel inhibitor of apoptosis protein family which expressed in human cancers. The molecular detection of bladder cancer by targeting Survivin as a novel marker may be useful in the occurrence and progression of cancer. We genotyped Survivin −31G>C, −1547A>G and −241C>T by PCR-restriction fragment length polymorphism to evaluate the risk of bladder cancer (BC) in 200 BC patients and 200 healthy controls from North Indian cohort. We observed significant increased BC risk associated with variant CC genotype of Survivin −31G>C having 2.6 fold risk. The variant genotype of Survivin −1547A>G was significantly associated with BC risk (P = 0.047). In case of Survivin −241C>T the protective genotype for BC was heterozygous (P = 0.035). Smoking significantly modulated the risk in patients with Survivin −1547A>G polymorphism. Variant as well as hetero genotype of Survivin −31G>C was associated with reduced risk of recurrence (HR = 0.22 and 0.35) in BC patients receiving BCG treatment thus showing least survival. Furthermore, the haplotype analysis revealed C–A–T haplotype to be associated with reduced BC risk. Our findings suggested that the functional polymorphism −31G>C, −1547A>G and −241C>T in the promoter of Survivin gene may play a significant role in mediating the BC risk among North Indian cohort.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sinha R, Anderson DE, McDonald SS, Greenwald P (2003) Cancer risk and diet in India. J Postgrad Med 49(3):222–228

    PubMed  CAS  Google Scholar 

  2. Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R (2008) Apoptotic pathways in tumor progression and therapy. Adv Exp Med Biol 615:47–79

    Article  PubMed  CAS  Google Scholar 

  3. Altieri DC (2008) Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8(1):61–70

    Article  PubMed  CAS  Google Scholar 

  4. Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3(1):46–54

    Article  PubMed  CAS  Google Scholar 

  5. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3(8):917–921

    Article  PubMed  CAS  Google Scholar 

  6. Fukuda S, Pelus LM (2006) Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 5(5):1087–1098

    Article  PubMed  CAS  Google Scholar 

  7. Ambrosini G, Adida C, Sirugo G, Altieri DC (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273(18):11177–11182

    Article  PubMed  CAS  Google Scholar 

  8. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58(22):5071–5074

    PubMed  CAS  Google Scholar 

  9. Sarela AI, Scott N, Ramsdale J, Markham AF, Guillou PJ (2001) Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol 4:305–310

    Article  Google Scholar 

  10. Kajiwara Y, Yamasaki F, Hama S, Yahara K, Yoshioka H, Sugiyama K, Arita K, Kurisu K (2003) Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer 97(4):1077–1083

    Article  PubMed  Google Scholar 

  11. Vischioni B, van der Valk P, Span SW, Kruyt FA, Rodriguez JA, Giaccone G (2004) Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann Oncol 15(11):1654–1660

    Article  PubMed  CAS  Google Scholar 

  12. Mellai M, Caldera V, Patrucco A, Annovazzi L, Schiffer D (2008) Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis. Anticancer Res 28(1A):109–118

    PubMed  CAS  Google Scholar 

  13. Dai J, Jin G, Dong J, Chen Y, Xu L, Hu Z, Shen H (2010) Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival. J Thorac Oncol 5(11):1748–1754

    Article  PubMed  Google Scholar 

  14. O’Connor DS, Wall NR, Porter AC, Altieri DC (2002) A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2(1):43–54

    Article  PubMed  Google Scholar 

  15. Sharp DJ, Rogers GC, Scholey JM (2000) Microtubule motors in mitosis. Nature 407(6800):41–47

    Article  PubMed  CAS  Google Scholar 

  16. Xu Y, Fang F, Ludewig G, Jones G, Jones D (2004) A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol 23(9):527–537

    PubMed  CAS  Google Scholar 

  17. Borbély AA, Murvai M, Szarka K, Kónya J, Gergely L, Hernádi Z, Veress G (2007) Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol 60(3):303–306

    Article  PubMed  Google Scholar 

  18. Jang JS, Kim KM, Kang KH, Choi JE, Lee WK, Kim CH, Kang YM, Kam S, Kim IS, Jun JE, Jung TH, Park JY (2008) Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60(1):31–39

    Article  PubMed  Google Scholar 

  19. Yang L, Zhu H, Zhou B, Gu H, Yan H, Tang N, Dong H, Sun Q, Cong R, Chen G, Wang B (2009) The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Dig Dis Sci 54(5):1021–1028

    Article  PubMed  CAS  Google Scholar 

  20. Wang YH, Chiou HY, Lin CT, Hsieh HY, Wu CC, Hsu CD, Shen CH (2009) Association between survivin gene promoter −31C/G polymorphism and urothelial carcinoma risk in Taiwanese population. Urology 73(3):670–674

    Article  PubMed  Google Scholar 

  21. Cheng ZJ, Hu LH, Huang SJ (2008) Correlation of −31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma. Ai Zheng 27(3):258–263

    PubMed  CAS  Google Scholar 

  22. Colombel M, Soloway M, Akaza H et al (2008) Epidemiology, staging, grading, and risk stratification of bladder cancer. Eur Urol Suppl 7:618–626

    Article  Google Scholar 

  23. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16(3):1215

    Article  PubMed  CAS  Google Scholar 

  24. Han CH, Wei Q, Lu KK, Liu Z, Mills GB, Wang LE (2009) Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer. Int J Clin Exp Med 2(4):289–299

    PubMed  CAS  Google Scholar 

  25. Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B (2011) Role of survivin gene promoter polymorphism (−31G>C) in susceptibility and survival of esophageal cancer in northern India. Ann Surg Oncol 18(3):880–887

    Article  PubMed  Google Scholar 

  26. Kawata N, Tsuchiya N, Horikawa Y, Inoue T, Tsuruta H, Maita S, Sato S, Mitobe Y, Narita S, Habuchi T (2010) Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility. Int J Cancer 129(8):1872–1880

    Google Scholar 

  27. Ma F, Zhang H, Zhai Y, Huang W, Zhao C, Ou S, Zhou H, Yuan W, Wang Z, Wang H, Yue W, Yu L, Li P, Xia X, Cai M, Zhang Y, Cui Y, He F, Ma Y, Zhou G (2011) Functional polymorphism −31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among Chinese. PLoS One 6(2):e16748

    Article  PubMed  CAS  Google Scholar 

  28. Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D (2004) Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst 96(13):1030–1036

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The study was supported by grant from Department of Science and Technology (DST), New Delhi Govt. of India. The authors are thankful to the urologists in the department for providing the details of the clinical samples.

Author information

Authors and Affiliations

  1. Department of Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow, 226014, Uttar Pradesh, India

    Praveen Kumar Jaiswal, Anil Mandhani & Rama Devi Mittal

  2. Department of Urology, Chatrapati Sahuji Maharaj Medical University, Lucknow, 226014, Uttar Pradesh, India

    Apul Goel

Authors
  1. Praveen Kumar Jaiswal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Apul Goel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anil Mandhani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rama Devi Mittal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rama Devi Mittal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jaiswal, P.K., Goel, A., Mandhani, A. et al. Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort. Mol Biol Rep 39, 5615–5621 (2012). https://doi.org/10.1007/s11033-011-1366-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-011-1366-1

Keywords

Search

Navigation